Viva Biotech Holdings (HKG:1873)
Hong Kong
· Delayed Price · Currency is HKD 2.440
+0.280 (12.96%)
Mar 10, 2026, 4:08 PM HKT
Viva Biotech Holdings Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 4,558 | 1,817 | 2,249 | 3,352 | 9,045 | 17,492 | Upgrade
|
| Market Cap Growth | 63.49% | -19.19% | -32.91% | -62.94% | -48.29% | 145.61% | Upgrade
|
| Enterprise Value | 4,850 | 2,374 | 4,227 | 5,809 | 10,494 | 15,958 | Upgrade
|
| Last Close Price | 2.16 | 0.86 | 1.05 | 1.75 | 4.71 | 9.13 | Upgrade
|
| PE Ratio | 31.59 | 10.21 | - | - | 25.63 | - | Upgrade
|
| Forward PE | 7.63 | 5.15 | 5.15 | 5.17 | 10.88 | 23.68 | Upgrade
|
| PS Ratio | 2.26 | 0.86 | 0.95 | 1.25 | 3.50 | 21.13 | Upgrade
|
| PB Ratio | 1.06 | 0.45 | 0.55 | 0.82 | 1.88 | 3.92 | Upgrade
|
| P/TBV Ratio | 2.98 | 1.33 | 1.84 | 3.05 | 6.01 | 10.23 | Upgrade
|
| P/FCF Ratio | 19.41 | 9.32 | 10.43 | 21.69 | - | - | Upgrade
|
| P/OCF Ratio | 11.83 | 4.57 | 5.32 | 7.68 | 94.67 | 341.11 | Upgrade
|
| PEG Ratio | - | 0.81 | 0.81 | 0.81 | 0.81 | 0.39 | Upgrade
|
| EV/Sales Ratio | 2.41 | 1.12 | 1.78 | 2.16 | 4.06 | 19.28 | Upgrade
|
| EV/EBITDA Ratio | 9.93 | 5.16 | 9.81 | 11.78 | 23.11 | 81.76 | Upgrade
|
| EV/EBIT Ratio | 19.41 | 9.71 | 19.92 | 19.32 | 36.09 | 119.41 | Upgrade
|
| EV/FCF Ratio | 20.65 | 12.17 | 19.61 | 37.58 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.30 | 0.34 | 0.52 | 0.78 | 0.68 | 0.79 | Upgrade
|
| Debt / EBITDA Ratio | 2.59 | 2.90 | 4.71 | 6.25 | 6.81 | 16.25 | Upgrade
|
| Debt / FCF Ratio | 5.39 | 7.01 | 9.72 | 20.65 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.06 | 0.09 | 0.24 | 0.60 | 0.47 | 0.16 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.58 | 0.79 | 2.22 | 4.91 | 5.01 | 3.72 | Upgrade
|
| Net Debt / FCF Ratio | 1.18 | 1.87 | 4.43 | 15.68 | -3.80 | -1.11 | Upgrade
|
| Asset Turnover | 0.26 | 0.27 | 0.28 | 0.30 | 0.26 | 0.14 | Upgrade
|
| Inventory Turnover | 4.24 | 4.88 | 4.84 | 5.61 | 7.33 | 4.53 | Upgrade
|
| Quick Ratio | 1.22 | 1.26 | 1.03 | 0.44 | 1.44 | 3.75 | Upgrade
|
| Current Ratio | 1.76 | 1.67 | 1.32 | 0.73 | 2.14 | 4.56 | Upgrade
|
| Return on Equity (ROE) | 5.87% | 5.92% | -2.74% | -13.41% | 7.84% | -13.69% | Upgrade
|
| Return on Assets (ROA) | 2.03% | 1.98% | 1.57% | 2.08% | 1.83% | 1.40% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.41% | 3.96% | 3.74% | 4.62% | 4.04% | 4.28% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.90% | 3.90% | 3.30% | 5.10% | 3.30% | 1.50% | Upgrade
|
| Earnings Yield | 4.14% | 9.80% | -5.69% | -17.82% | 3.90% | -2.63% | Upgrade
|
| FCF Yield | 5.15% | 10.73% | 9.59% | 4.61% | -6.61% | -3.73% | Upgrade
|
| Dividend Yield | - | - | - | - | - | 0.30% | Upgrade
|
| Payout Ratio | - | - | - | - | 5.66% | - | Upgrade
|
| Buyback Yield / Dilution | -48.61% | -41.39% | -5.91% | 2.81% | -25.41% | -5.83% | Upgrade
|
| Total Shareholder Return | -48.61% | -41.39% | -5.91% | 2.81% | -25.41% | -5.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.